Each 5ml dose contains: Cell-free pilus antigen of K88ab, K88ac, K99, 987P, Purified toxoids ofC.perfringens Type B and purified toxoids of Types C and D, as well as the adjuvant Aluminium hydroxide (less than 15 mg aluminium) and the excipient Thiomersal (0.01% w/v).
Dosage: Sows and gilts: 5ml.
Administer: By subcutaneous injection preferably behind the ear. The bottle should be well shaken before vaccine is withdrawn.
Primary vaccination scheme: The initial course consists of two doses: First dose: given at service or, if necessary, at any time up to 6 weeks before farrowing. Second dose: given two weeks before farrowing is expected.
Re-vaccination scheme: Given two weeks before farrowing is expected.
Withdrawal Period: Zero days.
The vaccine is safe for use during pregnancy. No information is available on specific use during lactation.
Occasional hypersensitivity reactions may occur. Prompt subcutaneous administration of adrenalin may relieve the condition.
Syringes and needles should be sterilised before use and the injection should be made through an area of clean, dry skin, taking precautions against contamination.
In most pigs, a slight to moderate swelling (up to 6 cm) may be seen at the injection site after vaccination. The swelling will decline and disappear but may last from 14 to 21 days in some pigs. No increased reactions have been seen after administration of an overdose.